Amphetamine-like stimulant remains in dietary supplements 2 years after FDA discovery

April 8, 2015 3:07 PM

30 0

The 2014 study from the Food and Drug Administration (FDA), published in the Journal of Pharmaceutical and Biomedical Analysis, revealed that nine of the tested 21 dietary supplements marketed for weight loss, improved cognitive function or enhanced athletic performance containing a plant extract called Acacia rigidula also contained beta-methylphenylethylamine (BMPEA).

BMPEA is a synthetic compound closely related to amphetamine. Though the safety of the substance has not been tested in humans, studies in cats and dogs have shown it to increase blood pressure and heart rate - conditions known to raise the risk of heart attack and stroke in humans.

Read more

To category page